PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays

Post-marketing Clinical Investigation to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays

The brief of this observational study is to evaluate usage, efficacy, safety and patient satisfaction of a range of hypertonic seawater-based decongestant nasal sprays in general population.

The main questions it aims to answer are:

• Usage,
• Efficacy,
• Safety,
• Satisfaction, in real-life usage with children, adults and pregnant or breastfeeding women. Participants will use the nasal spray as usual habits and complete daily questionnaires.

Inclusion Criteria:

• Subject coming to pharmacy for spontaneous purchase of one of the medical device under investigation.
• Subject willing to buy one of the medical device under investigation following advice from pharmacist, general practitioner or any other health care professionals.
• Adult and children from 3 years old in compliance with the information for use.
• Subject presenting moderate nasal congestion or more.
• Subject agreeing to follow the study requirements during the whole study period.
• Subject having daily access to internet in order to answer online questionnaire.
• Subject able to understand verbal and written local language and in capacity to fill-in questionnaire himself.
• Subject able to give inform consent.

Exclusion Criteria:

• Subject with contraindications according to the information for use.
• Hypersensitivity or know allergy to any component of the product.
• Subject taking part in another clinical study or being in the exclusion period of another clinical study.
• Subject already included once in this study or having a family member already included in this study for the same indication.
• Vulnerable subject (except children, pregnant and breastfeeding women).